Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
Authors:
- Anna M AloisiAAAnna M Aloisi
- Ilaria CeccarelliICIlaria Ceccarelli
- Maria CarlucciMCMaria Carlucci
- Annalisa SumanASAnnalisa Suman
- Gianfranco SindacoGSGianfranco Sindaco
- Sergio MameliSMSergio Mameli
- Valentina PaciVPValentina Paci
- Laura RavaioliLRLaura Ravaioli
- Giandomenico PassavantiGPGiandomenico Passavanti
- Valeria BachioccoVBValeria Bachiocco
- Gilberto PariGPGilberto Pari
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 9 (1) , 26
Abstract
In male patients suffering from chronic pain, opioid administration induces severe hypogonadism, leading to impaired physical and psychological conditions such as fatigue, anaemia and depression. Hormone replacement therapy is rarely considered for these hypogonadic patients, notwithstanding the various pharmacological solutions available.Keywords
This publication has 33 references indexed in Scilit:
- Aromatase and 5-alpha Reductase Gene Expression: Modulation by Pain and Morphine Treatment in Male RatsMolecular Pain, 2010
- The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine SystemsEndocrine Reviews, 2009
- Effects of morphine on testosterone levels in rat C6 glioma cells: Modulation by anastrozoleJournal of Cellular Physiology, 2009
- Oral Opioids for Chronic Non-cancer Pain: Higher Prevalence of Hypogonadism in Men than in WomenExperimental and Clinical Endocrinology & Diabetes, 2008
- Depressive symptoms and risk of stroke: the Rotterdam StudyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Opioid Endocrinopathy in Women Consuming Prescribed Sustained-Action Opioids for Control of Nonmalignant PainThe Journal of Pain, 2008
- Testosterone treatment to mimic hormone physiology in androgen replacement therapyExpert Opinion on Biological Therapy, 2007
- Open-Label Pilot Study of Testosterone Patch Therapy in Men With Opioid-Induced Androgen DeficiencyThe Journal of Pain, 2006
- Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF)Pain, 2005
- Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sitesJournal of Steroid Biochemistry, 1989